ATE524446T1 - Sulfatierte benzimidazolon-derivate mit gemischter serotonin-rezeptor-affinität - Google Patents
Sulfatierte benzimidazolon-derivate mit gemischter serotonin-rezeptor-affinitätInfo
- Publication number
- ATE524446T1 ATE524446T1 AT07857748T AT07857748T ATE524446T1 AT E524446 T1 ATE524446 T1 AT E524446T1 AT 07857748 T AT07857748 T AT 07857748T AT 07857748 T AT07857748 T AT 07857748T AT E524446 T1 ATE524446 T1 AT E524446T1
- Authority
- AT
- Austria
- Prior art keywords
- sulfated
- serotonin receptor
- receptor affinity
- mixed serotonin
- benzimidazolone derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/26—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Gynecology & Obstetrics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP06126689 | 2006-12-20 | ||
| PCT/EP2007/064120 WO2008074795A1 (en) | 2006-12-20 | 2007-12-18 | Sulfated benzimidazolone derivatives having mixed serotonine receptor affinity |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE524446T1 true ATE524446T1 (de) | 2011-09-15 |
Family
ID=39204903
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT07857748T ATE524446T1 (de) | 2006-12-20 | 2007-12-18 | Sulfatierte benzimidazolon-derivate mit gemischter serotonin-rezeptor-affinität |
Country Status (6)
| Country | Link |
|---|---|
| US (3) | US8722682B2 (de) |
| EP (1) | EP2097389B1 (de) |
| JP (1) | JP2010513390A (de) |
| AT (1) | ATE524446T1 (de) |
| CA (1) | CA2672957C (de) |
| WO (1) | WO2008074795A1 (de) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UA78974C2 (en) | 2001-10-20 | 2007-05-10 | Boehringer Ingelheim Pharma | Use of flibanserin for treating disorders of sexual desire |
| US10675280B2 (en) | 2001-10-20 | 2020-06-09 | Sprout Pharmaceuticals, Inc. | Treating sexual desire disorders with flibanserin |
| CA2617546C (en) | 2005-08-03 | 2014-07-15 | Boehringer Ingelheim International Gmbh | Use of flibanserin in the treatment of obesity |
| WO2008000760A1 (en) | 2006-06-30 | 2008-01-03 | Boehringer Ingelheim International Gmbh | Flibanserin for the treatment of urinary incontinence and related diseases |
| EP2097389B1 (de) * | 2006-12-20 | 2011-09-14 | Boehringer Ingelheim International GmbH | Sulfatierte benzimidazolon-derivate mit gemischter serotonin-rezeptor-affinität |
| PE20091188A1 (es) | 2007-09-12 | 2009-08-31 | Boehringer Ingelheim Int | Compuesto 1-[2-(4-(3-trifluorometil-fenil)piperazin-1-il)etil]-2,3-dihidro-1h-benzimidazol-2-ona (flibanserina), sus sales de adicion y composiciones farmaceuticas que los contienen |
| CA2686480A1 (en) | 2008-12-15 | 2010-06-15 | Boehringer Ingelheim International Gmbh | New salts |
| US8901304B1 (en) | 2013-11-05 | 2014-12-02 | King Fahd University Of Petroleum And Minerals | Benzo[D]imidazole derivatives of piperidine and piperazine |
| CN116554127B (zh) * | 2022-01-28 | 2025-03-21 | 成都麻沸散医药科技有限公司 | 哌嗪取代苯酚类衍生物及其用途 |
Family Cites Families (40)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1251144B (it) * | 1991-07-30 | 1995-05-04 | Boehringer Ingelheim Italia | Derivati del benzimidazolone |
| US6083947A (en) * | 1996-01-29 | 2000-07-04 | The Regents Of The University Of California | Method for treating sexual dysfunctions |
| US6579968B1 (en) | 1999-06-29 | 2003-06-17 | Palatin Technologies, Inc. | Compositions and methods for treatment of sexual dysfunction |
| IT1313625B1 (it) | 1999-09-22 | 2002-09-09 | Boehringer Ingelheim Italia | Derivati benzimidazolonici aventi affinita' mista per i recettori diserotonina e dopamina. |
| DE19961334A1 (de) * | 1999-12-17 | 2001-06-21 | Roehm Gmbh | Spritzgußverfahren für neutrale und säuregruppenhaltige (Meth)acrylat-Copolymere |
| US6586435B2 (en) * | 2000-09-19 | 2003-07-01 | Boehringer Ingelheim Pharma Kg | Benzimidazolone derivatives displaying affinity at the serotonin and dopamine receptors |
| JP5062938B2 (ja) | 2000-09-19 | 2012-10-31 | ベーリンガー インゲルハイム ファルマ ゲゼルシャフト ミット ベシュレンクテル ハフツング ウント コンパニー コマンディトゲゼルシャフト | セロトニン受容体及びドーパミン受容体にアフィニティーを有する新規n,n’−二置換ベンゾイミダゾロン誘導体 |
| US6521623B1 (en) * | 2000-09-19 | 2003-02-18 | Boehringer Ingelheim Pharma Kg | N,N'-disubstituted benzimidazolone derivatives with affinity at the serotonin and dopamine receptors |
| EP1256343B1 (de) | 2001-05-11 | 2006-07-05 | Jürgen K. Dr. Beck | Flibanserin zur Behandlung extrapyramidaler Bewegungsstörungen |
| WO2003007949A1 (en) | 2001-07-18 | 2003-01-30 | Merck & Co., Inc. | Bridged piperidine derivatives as melanocortin receptor agonists |
| HRP20040107B1 (hr) | 2001-08-02 | 2012-02-29 | Bidachem S.P.A. | Stabilni polimorf flibanserina, tehnički postupak njegova pripravljanja, te njegova primjena u proizvodnji lijekova |
| US7183410B2 (en) * | 2001-08-02 | 2007-02-27 | Bidachem S.P.A. | Stable polymorph of flibanserin |
| US20030060475A1 (en) * | 2001-08-10 | 2003-03-27 | Boehringer Ingelheim Pharma Kg | Method of using flibanserin for neuroprotection |
| HUP0202719A3 (en) | 2001-08-21 | 2006-01-30 | Pfizer Prod Inc | Pharmaceutical compositions for the treatment of female sexual dysfunctions |
| UA78974C2 (en) * | 2001-10-20 | 2007-05-10 | Boehringer Ingelheim Pharma | Use of flibanserin for treating disorders of sexual desire |
| DE10209982A1 (de) | 2002-03-07 | 2003-09-25 | Boehringer Ingelheim Pharma | Oral zu applizierende Darreichungsform für schwerlösliche basische Wirkstoffe |
| CN101002780A (zh) | 2002-05-22 | 2007-07-25 | 贝林格尔英格海姆法玛两合公司 | 新型含氟班色林多晶型物a的药物组合物 |
| US20040048877A1 (en) * | 2002-05-22 | 2004-03-11 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Pharmaceutical compositions containing flibanserin |
| US20040193452A1 (en) * | 2003-01-06 | 2004-09-30 | Laura Berman | Method and system for computerized sexual function assessment of female users |
| US7041193B2 (en) | 2003-05-14 | 2006-05-09 | L & L Products, Inc. | Method of adhering members and an assembly formed thereby |
| US20050065158A1 (en) * | 2003-07-16 | 2005-03-24 | Pfizer Inc. | Treatment of sexual dysfunction |
| GB2413148A (en) | 2004-04-16 | 2005-10-19 | Per-Olof Eriksson | Loft ladder assembly |
| KR20070014184A (ko) * | 2004-04-22 | 2007-01-31 | 베링거 인겔하임 인터내셔날 게엠베하 | 성기능 장애 치료용 신규 약제학적 조성물 ⅱ |
| US20050239798A1 (en) * | 2004-04-22 | 2005-10-27 | Boehringer Ingelheim Pharmaceuticals, Inc. | Method for the treatment of premenstrual and other female sexual disorders |
| KR200358845Y1 (ko) | 2004-05-04 | 2004-08-12 | 김대연 | 구강내 환부에 삽입되는 광 섬유봉이 구비된 투시촬영장치 |
| JP2008540673A (ja) * | 2005-05-19 | 2008-11-20 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 薬剤誘発性性機能不全の治療方法 |
| CA2617546C (en) * | 2005-08-03 | 2014-07-15 | Boehringer Ingelheim International Gmbh | Use of flibanserin in the treatment of obesity |
| JP2009510099A (ja) * | 2005-09-30 | 2009-03-12 | スミスクライン・ビーチャム・コーポレイション | 医薬組成物 |
| WO2007048803A1 (en) * | 2005-10-29 | 2007-05-03 | Boehringer Ingelheim International Gmbh | Benzimidazolone derivatives for the treatment of premenstrual and other female sexual disorders |
| US20070105869A1 (en) | 2005-11-08 | 2007-05-10 | Stephane Pollentier | Use of flibanserin for the treatment of pre-menopausal sexual desire disorders |
| DE102006010870A1 (de) | 2006-03-07 | 2007-09-13 | Henkel Kgaa | Kosmetische Mittel mit Purin und/oder Purinderivaten I |
| WO2008000760A1 (en) * | 2006-06-30 | 2008-01-03 | Boehringer Ingelheim International Gmbh | Flibanserin for the treatment of urinary incontinence and related diseases |
| CA2660476C (en) * | 2006-08-14 | 2015-11-17 | Boehringer Ingelheim International Gmbh | Formulations of flibanserin and method for manufacturing the same |
| WO2008022932A2 (en) | 2006-08-25 | 2008-02-28 | Boehringer Ingelheim International Gmbh | Controlled release system and method for manufacturing the same |
| EP2097389B1 (de) | 2006-12-20 | 2011-09-14 | Boehringer Ingelheim International GmbH | Sulfatierte benzimidazolon-derivate mit gemischter serotonin-rezeptor-affinität |
| BRPI0807774A2 (pt) | 2007-02-16 | 2014-06-17 | 3M Innovative Properties Co | Método e aparelho para iluminar material para inspeção automatizada |
| CA2682015A1 (en) | 2007-03-28 | 2008-10-02 | Boehringer Ingelheim International Gmbh | Pharmaceutical compositions comprising flibanserin and a further agent in the treatment of sexual disorders |
| US8486452B2 (en) * | 2007-07-20 | 2013-07-16 | Mylan Pharmaceuticals Inc. | Stabilized tolterodine tartrate formulations |
| PE20091188A1 (es) * | 2007-09-12 | 2009-08-31 | Boehringer Ingelheim Int | Compuesto 1-[2-(4-(3-trifluorometil-fenil)piperazin-1-il)etil]-2,3-dihidro-1h-benzimidazol-2-ona (flibanserina), sus sales de adicion y composiciones farmaceuticas que los contienen |
| CA2686480A1 (en) * | 2008-12-15 | 2010-06-15 | Boehringer Ingelheim International Gmbh | New salts |
-
2007
- 2007-12-18 EP EP07857748A patent/EP2097389B1/de not_active Not-in-force
- 2007-12-18 AT AT07857748T patent/ATE524446T1/de not_active IP Right Cessation
- 2007-12-18 WO PCT/EP2007/064120 patent/WO2008074795A1/en not_active Ceased
- 2007-12-18 CA CA2672957A patent/CA2672957C/en not_active Expired - Fee Related
- 2007-12-18 JP JP2009542029A patent/JP2010513390A/ja not_active Ceased
- 2007-12-18 US US12/518,574 patent/US8722682B2/en not_active Expired - Fee Related
-
2014
- 2014-05-08 US US14/273,126 patent/US20150011564A1/en not_active Abandoned
-
2015
- 2015-04-20 US US14/690,981 patent/US20150368204A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP2097389B1 (de) | 2011-09-14 |
| US20150368204A1 (en) | 2015-12-24 |
| US8722682B2 (en) | 2014-05-13 |
| EP2097389A1 (de) | 2009-09-09 |
| WO2008074795A1 (en) | 2008-06-26 |
| US20150011564A1 (en) | 2015-01-08 |
| JP2010513390A (ja) | 2010-04-30 |
| US20110015207A1 (en) | 2011-01-20 |
| CA2672957C (en) | 2015-04-14 |
| CA2672957A1 (en) | 2008-06-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX338707B (es) | Compuestos heterociclicos activadores de proteina cinasa activada por 5'-amp (ampk) y metodos para emplearlos. | |
| ATE544767T1 (de) | Triazoloä4,5-düpyramidinderivate und deren verwendung als purinrezeptorantagonisten | |
| ATE524466T1 (de) | 3-azabicycloä3.3.0üoktanverbindungen | |
| MX2009007713A (es) | Derivados de piridazina, procedimientos para su preparacion y su uso como fungicidas. | |
| NO20083630L (no) | Nye pyridinderivater | |
| MX2010005298A (es) | Compuestos de carboxamida, sulfonamida y amina para trastornos metabolicos. | |
| ATE483707T1 (de) | 2-cyclopropylthiazolderivate | |
| MX2009003645A (es) | Azaciclilaminas n-sustituidas como antagonistas de histamina-3. | |
| CR10243A (es) | "bencimidazoles 2-sustituidos como modulares de receptor de androgeno selectivos" | |
| MX2010002760A (es) | Derivados de isoquinolinilo e isoindolinilo como antagonistas de la histamina-3. | |
| MX2009008284A (es) | Compuestos triciclicos y su uso como moduladores de receptor de glucocorticoides. | |
| MX2009011205A (es) | Derivados de 2-iminoisotiazol como ligandos del receptor canabinoide. | |
| MY147649A (en) | Benzimidazole derivatives useful in treatment of vallinoid receptor trpv1 related disorders | |
| TW200800958A (en) | N-substituted-azacyclylamines as histamine-3 antagonists | |
| MX2011006843A (es) | Dihidropiridona-amidas como moduladores de p2x7. | |
| CR11866A (es) | Derivados de piridino-piridinonas, su preparacion y su aplicacion en terapeutica | |
| BR112015013463A2 (pt) | derivados de carboxamida indol como antagonistas do receptor de p2x7 | |
| MX2010005649A (es) | Compuestos novedosos como ligandos del receptor canabinoide y sus usos. | |
| JO2682B1 (en) | Derivatives of alkynil-8.1-naphthayridone, preparations thereof and therapeutic use thereof | |
| MY183039A (en) | Pyridin-2-yl derivatives as immunomodulating agents | |
| ECSP109961A (es) | Derivados de indol-2-ona disustituidos en 3, su preparación y su aplicación en terapéutica | |
| MY146671A (en) | Tetrahydronaphthaline derivatives, methods for the production and use thereof as anti-inflammatory agents | |
| CY1110276T1 (el) | Αμινοαρυλο σουλφοναμιδικα παραγωγα ως λειτουργικοι συνδετες 5-ητ6 | |
| MY149973A (en) | 3-carboxypropyl-aminotetralin derivatives as mu opioid receptor antagonists | |
| CR10371A (es) | Compuestos heterociclicos apropiados para tratar trastornos que responden a la moduilacion del receptor de serotonina 5ht6 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |